203 related articles for article (PubMed ID: 10333542)
41. Expression of tissue inhibitor of metalloproteinases-1 in the human corpus luteum after luteal rescue.
Duncan WC; McNeilly AS; Illingworth PJ
J Endocrinol; 1996 Jan; 148(1):59-67. PubMed ID: 8568472
[TBL] [Abstract][Full Text] [Related]
42. Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary.
Bagavandoss P
J Endocrinol; 1998 Aug; 158(2):221-8. PubMed ID: 9771466
[TBL] [Abstract][Full Text] [Related]
43. Effects of a GnRH agonist on oocyte number and maturation in mice superovulated with eCG and hCG.
Kanter M; Yildiz C; Meral I; Koc A; Tasal I
Theriogenology; 2004 Jan; 61(2-3):393-8. PubMed ID: 14662138
[TBL] [Abstract][Full Text] [Related]
44. Specific binding sites for gonadotrophin-releasing hormone, LH/chorionic gonadotrophin, low-density lipoprotein, prolactin and FSH in homogenates of human corpus luteum. II: Concentrations throughout the luteal phase of the menstrual cycle and early pregnancy.
Bramley TA; Stirling D; Swanston IA; Menzies GS; McNeilly AS; Baird DT
J Endocrinol; 1987 May; 113(2):317-27. PubMed ID: 3035053
[TBL] [Abstract][Full Text] [Related]
45. Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes.
Théret N; Musso O; L'Helgoualc'h A; Clément B
Am J Pathol; 1997 Jan; 150(1):51-8. PubMed ID: 9006321
[TBL] [Abstract][Full Text] [Related]
46. Cyclic changes in the responsiveness of regressing corpora lutea to the luteolytic effects of prolactin in rats.
Gaytán F; Bellido C; Morales C; Sánchez-Criado JE
Reproduction; 2001 Sep; 122(3):411-7. PubMed ID: 11603369
[TBL] [Abstract][Full Text] [Related]
47. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
48. [Regulation of follicular luteinization by an agonist of gonadotropin-releasing hormone (GnRH)].
Andreu C; Parborell F; Vanzulli S; Tesone M
Medicina (B Aires); 1997; 57(1):83-6. PubMed ID: 9435376
[TBL] [Abstract][Full Text] [Related]
49. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
50. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
[TBL] [Abstract][Full Text] [Related]
51. Collagenase, gelatinase, and proteoglycanase messenger ribonucleic acid expression and activity during luteal development, maintenance, and regression in the pseudopregnant rat ovary.
Nothnick WB; Keeble SC; Curry TE
Biol Reprod; 1996 Mar; 54(3):616-24. PubMed ID: 8835383
[TBL] [Abstract][Full Text] [Related]
52. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of long-form prolactin receptor mRNA during prolactin-induced luteal regression.
Bowen JM; Telleria CM; Towns R; Keyes PL
Eur J Endocrinol; 2000 Aug; 143(2):285-92. PubMed ID: 10913950
[TBL] [Abstract][Full Text] [Related]
54. Heterogeneity in the luteal population following superovulation with pregnant mare serum gonadotrophin and human chorionic gonadotrophin in the sheep.
Hunter MG; Southee JA
J Endocrinol; 1989 Jun; 121(3):459-65. PubMed ID: 2754372
[TBL] [Abstract][Full Text] [Related]
55. Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation.
Yu M; Sato H; Seiki M; Spiegel S; Thompson EW
FEBS Lett; 1997 Aug; 412(3):568-72. PubMed ID: 9276468
[TBL] [Abstract][Full Text] [Related]
56. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
[TBL] [Abstract][Full Text] [Related]
57. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
58. Identification of matrix metalloproteinases and metalloproteinase inhibitors in bovine corpora lutea and their variation during the estrous cycle.
Goldberg MJ; Moses MA; Tsang PC
J Anim Sci; 1996 Apr; 74(4):849-57. PubMed ID: 8728007
[TBL] [Abstract][Full Text] [Related]
59. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
60. Cyclic adenosine monophosphate signaling in the primate corpus luteum: maintenance of protein kinase A activity throughout the luteal phase of the menstrual cycle.
Benyo DF; Zeleznik AJ
Endocrinology; 1997 Aug; 138(8):3452-8. PubMed ID: 9231800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
